Deutsche Börse

(IN BRIEF) Clearstream, Deutsche Börse Group’s post-trade business, has unveiled a next-generation digital securities infrastructure designed to support both traditional and tokenized securities markets. The new digital-first and fully hybrid platform will allow market participants to hold and combine traditional … Read the full press release →

(IN BRIEF) HOCHTIEF will join Germany’s DAX index following the latest review by Deutsche Börse, with the inclusion taking effect on June 22, 2026. The move marks an important milestone in the Group’s more than 150-year history and reflects its … Read the full press release →

(IN BRIEF) Eckert & Ziegler SE has received the Best Managed Companies Award for the third consecutive year, recognizing the company as one of Germany’s outstandingly managed medium-sized businesses. The award, presented by Deloitte Private, UBS, Frankfurter Allgemeine Zeitung and … Read the full press release →

(IN BRIEF) Thales and Google Cloud have announced a strategic partnership to launch a new sovereign cloud offering in Germany, aimed at public sector organisations and highly regulated industries that require strict control over sensitive data and compliance with German … Read the full press release →

(IN BRIEF) Wiener Börse AG and Deutsche Börse AG have extended their technology partnership until 2033, ensuring the continued use of the T7 trading system across multiple Central and Eastern European exchanges. The agreement maintains a stable and familiar trading … Read the full press release →

(IN BRIEF) The Deutsche Börse Photography Foundation has named Raquel Villar-Pérez as the first recipient of its Curatorial Fellowship, a two-year programme supporting research-based exhibition development in contemporary photography. The initiative aims to promote curatorial practice, enhance international collaboration, and … Read the full press release →

(IN BRIEF) Deutsche Börse Group has invested USD 15 million in MerQube, a US-based index technology firm, acquiring a minority stake alongside 7RIDGE. The partnership aims to enhance innovation in index-based investing, leveraging MerQube’s advanced SaaS platform and expertise in … Read the full press release →

(IN BRIEF) Eckert & Ziegler has secured MDR certification for its Ru-106 eye applicators, ensuring continued availability of a critical treatment for eye cancer patients in the EU. The devices, used in brachytherapy procedures for conditions such as uveal melanoma … Read the full press release →

(IN BRIEF) Clearstream and Euroclear Bank have launched new dematerialized Eurobond issuance services, enabling issuers to bring Eurobonds to market in fully digital form without the use of physical certificates. The initiative modernizes the issuance and post-trade lifecycle for the … Read the full press release →

(IN BRIEF) Klöckner & Co reported improved financial performance for fiscal year 2025 despite challenging market conditions. Operating income before material special effects increased to €171 million, while shipments rose slightly to 4.53 million tons. Although sales declined modestly to … Read the full press release →

(IN BRIEF) Eckert & Ziegler SE and Molecular Partners AG have entered into a partnership to develop and potentially manufacture DARPin-based radiopharmaceutical therapies for cancer treatment. Eckert & Ziegler will provide development services for Radio-DARPins using Actinium-225 and Lutetium-177 isotopes, … Read the full press release →

(IN BRIEF) Sirma Group Holding has begun trading in the Prime Standard segment of the Frankfurt Stock Exchange while maintaining its existing listing on the Bulgarian Stock Exchange through the EuroBridge segment, which allows simultaneous trading in Sofia and Frankfurt. … Read the full press release →

(IN BRIEF) Eckert & Ziegler and the Nuclear Physics Institute of the Czech Academy of Sciences have scaled up production of the critical medical isotope Actinium-225, moving from development into larger-scale manufacturing at facilities in Řež and Braunschweig. The expansion … Read the full press release →

(IN BRIEF) Eurex has highlighted a major improvement in market accessibility following Germany’s Financial Centre Promotion Act, which exempts non-EU market makers from prior licensing and local establishment requirements. The reform reduces administrative complexity and costs, making it easier for … Read the full press release →

(IN BRIEF) Schroders has launched its first active ETFs in Europe, bringing two of its flagship strategies — the $24 billion QEP Global Core equity strategy and the $3 billion Global Investment Grade Corporate Bond strategy — into UCITS ETF … Read the full press release →

(IN BRIEF) GEA has joined the DAX index, becoming one of Germany’s 40 largest listed companies following a strong rise in its market valuation and successful qualification via Deutsche Börse’s “Fast Entry” process. The company’s transformation, centered on innovation, sustainability, … Read the full press release →

(IN BRIEF) Euronext and Clearstream have announced a collaboration to upgrade Euronext Clearing’s collateral management for repos and additional asset classes. Clearstream will serve as a triparty agent, automating collateral selection, valuation, and substitution, while also handling settlement, custody, regulatory … Read the full press release →

(IN BRIEF) Eckert & Ziegler successfully hosted the 3rd annual Boston Radionuclide Theranostics Forum, bringing together industry leaders to discuss radionuclide theranostics’ role in transforming precision oncology. The event featured expert presentations on advancements in radiopharmaceuticals, clinical development challenges, and … Read the full press release →

(IN BRIEF) Eckert & Ziegler SE has been awarded the “Best Managed Companies Award” for the second time, a prestigious recognition celebrating excellence in strategy, innovation, culture, and governance. This accolade underscores the company’s continued leadership in supplying isotopes for … Read the full press release →

(IN BRIEF) Eckert & Ziegler Radiopharma GmbH has entered into a clinical manufacturing agreement with Pentixapharm AG to supply GMP-grade Y90-PentixaTher doses for use in ongoing trials. The radiolabeled therapy targets cancers overexpressing the CXCR4 receptor and supports a theranostic … Read the full press release →